CLARIFICATION AND AMENDMENT OF BIOMS LICENSE AGREEMENTBioms License Agreement • March 21st, 2008 • Autoimmune Inc • Biological products, (no disgnostic substances)
WHEREAS AutoImmune and BioMS entered into a Development and License Agreement dated August 1, 2000 (the “BioMS License”) addressing the grant of license to certain Patent Rights in the Field, specifically the administration of native myelin basic protein (MBP) peptides by injection to non-mucosal sites for the treatment of Multiple Sclerosis;
